ALKERMES PLC. (ALKS)
Alkermes to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Alkermes to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Five Below, Inc. Announces First Quarter Fiscal 2026 Financial Results
Edgewise Therapeutics - Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Immediate Report
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
Intuit Executive Mark Notarainni to Present at the Mizuho Technology Conference
Verastem Oncology Announces U.S. FDA Fast Track Designation for VS-7375, an Oral and Potential Best-in-Class Investigational KRAS G12D (ON/OFF) Inhibitor for the Treatment of KRAS G12D-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
McGrath Declares Quarterly Dividend